Coelho Rogerio Vivaldi, Director at Crinetics Pharmaceuticals, Inc. (CRNX), bought 5,000 shares at $22.06 ($110K) on 2023-06-08, disclosed to the SEC on 2023-06-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ONCE | SELL | 2016-07-19 | $371K | — | Filing → |
| ONCE | SELL | 2016-04-22 | $280K | — | Filing → |
| ONCE | SELL | 2015-10-14 | $1.2M | — | Filing → |